{"SPADE_UN_15644": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15644", "Peptide Name": "HS2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "CGAISLAPKLQIKES", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:CT26 (IC50=93.5±10.7 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "programmed cell death protein 1", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C68H120N18O21S", "Mass": 1557.85, "PI": 8.2, "Net Charge": 1, "Hydrophobicity": 0.29, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy", "Pubmed ID": "33360579", "Reference": "Bioorg Med Chem. 2021 Jan 15;30115951.", "Author": "Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33360579"}], "Frequent Amino Acids": "AIK", "Absent Amino Acids": "DFHMNORTUVWY", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 7, "Polar Residues": 8, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15643", "Similarity": 0.9333333333333333, "Sequence": "CGAISLAPKAQIKES"}, {"SPADE_ID": "SPADE_UN_15642", "Similarity": 0.9285714285714286, "Sequence": "CGAISLAKLQINES"}, {"SPADE_ID": "SPADE_UN_15647", "Similarity": 0.9230769230769231, "Sequence": "GAISLAPKLQINE"}]}}}